Revolutionizing TB treatment: Breakthrough antibiotics for a healthier future A comprehensive review

The current treatment regiment for DS-TB(Drug Resistant Tuberculosis) was defined by 1980's since then the emergency of HIV and escalation of Drug sensitive (DS-TB)forms of TB have presented new challenges.To face these challenges, achieve goals like shortening DS -TB treatment improving DR-TB treatment and making combined TB -HIV therapy easier. A range of new drugs and treatment strategies are currently being elevated. Phase 2B and 3 clinical trials are ongoing to access combinations involving in high dose rifamycins, 8methoxyquinolines,diarylquinolines and nitroimidazoles. The new drugs advantages will contribute towards the achievement of a new treatment regimen in future. Tuberculosis according to WHO: TB is a bacterial infection that mainly affects the lungs and it is caused by the bacteria mycobacterium tuberculosis.